Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shiro Oka

Showing results (411-420 of 477) with videos related to

Pageof 48
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 7, 2026
Efficacy and Safety of Second-Line Lenvatinib After First-Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular CarcinomaRyoichi Miura, Tomokazu Kawaoka, Saki Sueda, et al.
Digestive Diseases (Basel, Switzerland)|May 17, 2019
Age Affects Clinical Management after Noncurative Endoscopic Submucosal Dissection for Early Gastric CancerMitsuru Esaki, Waku Hatta, Tooru Shimosegawa, et al.
Hepatology International|April 26, 2023
Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failureSerami Murakami, Michio Imamura, Takuro Uchida, et al.
Internal Medicine (Tokyo, Japan)|September 3, 2025
The Efficacy and Safety of Atezolizumab Plus Bevacizumab after Durvalumab Plus Tremelimumab for the Treatment of Hepatocellular CarcinomaShinsuke Uchikawa, Tomokazu Kawaoka, Aiko Tanaka, et al.
Journal of Gastroenterology and Hepatology|October 16, 2023
Nationwide multicenter study on adverse events associated with a patency capsule: Additional survey of appropriate use of patency capsule studyTeppei Omori, Naoki Ohmiya, Kenji Watanabe, et al.
Surgical Endoscopy|February 27, 2019
Long-term outcomes after non-curative endoscopic submucosal dissection for early gastric cancer according to hospital volumes in Japan: a multicenter propensity-matched analysisOsamu Dohi, Waku Hatta, Takuji Gotoda, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 15, 2020
Predictors of invasive cancer of large laterally spreading colorectal tumors: A multicenter study in JapanKiyonori Kobayashi, Shinji Tanaka, Yoshitaka Murakami, et al.
Cancers|May 16, 2023
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-FetoproteinTakahiro Kinami, Kei Amioka, Tomokazu Kawaoka, et al.
Digestion|July 27, 2023
Current Status of Diagnosis and Treatment of Colorectal Cancer in Asian Countries: A Questionnaire SurveyHidenori Tanaka, Shiro Oka, Akiko Shiotani, et al.
Cancers|February 11, 2023
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma-Consideration of the Locations of Target LesionsShigeki Yano, Tomoki Kimura, Tomokazu Kawaoka, et al.
Pageof 48

Showing results (411-420 of 477) with videos related to

Sort By:
Pageof 48
Hepatology Research : the Official Journal of the Japan Society of Hepatology|February 7, 2026
Efficacy and Safety of Second-Line Lenvatinib After First-Line Durvalumab Plus Tremelimumab in Unresectable Hepatocellular CarcinomaRyoichi Miura, Tomokazu Kawaoka, Saki Sueda, et al.
Digestive Diseases (Basel, Switzerland)|May 17, 2019
Age Affects Clinical Management after Noncurative Endoscopic Submucosal Dissection for Early Gastric CancerMitsuru Esaki, Waku Hatta, Tooru Shimosegawa, et al.
Hepatology International|April 26, 2023
Serum interleukin-6 level predicts the prognosis for patients with alcohol-related acute-on-chronic liver failureSerami Murakami, Michio Imamura, Takuro Uchida, et al.
Internal Medicine (Tokyo, Japan)|September 3, 2025
The Efficacy and Safety of Atezolizumab Plus Bevacizumab after Durvalumab Plus Tremelimumab for the Treatment of Hepatocellular CarcinomaShinsuke Uchikawa, Tomokazu Kawaoka, Aiko Tanaka, et al.
Journal of Gastroenterology and Hepatology|October 16, 2023
Nationwide multicenter study on adverse events associated with a patency capsule: Additional survey of appropriate use of patency capsule studyTeppei Omori, Naoki Ohmiya, Kenji Watanabe, et al.
Surgical Endoscopy|February 27, 2019
Long-term outcomes after non-curative endoscopic submucosal dissection for early gastric cancer according to hospital volumes in Japan: a multicenter propensity-matched analysisOsamu Dohi, Waku Hatta, Takuji Gotoda, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|February 15, 2020
Predictors of invasive cancer of large laterally spreading colorectal tumors: A multicenter study in JapanKiyonori Kobayashi, Shinji Tanaka, Yoshitaka Murakami, et al.
Cancers|May 16, 2023
Evaluation of Response to Atezolizumab Plus Bevacizumab in Patients with Advanced Hepatocellular Carcinoma Using the Combination of Response Evaluation Criteria in Solid Tumors and Alpha-FetoproteinTakahiro Kinami, Kei Amioka, Tomokazu Kawaoka, et al.
Digestion|July 27, 2023
Current Status of Diagnosis and Treatment of Colorectal Cancer in Asian Countries: A Questionnaire SurveyHidenori Tanaka, Shiro Oka, Akiko Shiotani, et al.
Cancers|February 11, 2023
Effectiveness of Repeated Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma-Consideration of the Locations of Target LesionsShigeki Yano, Tomoki Kimura, Tomokazu Kawaoka, et al.
Pageof 48